19-371 - Expanded Access to Voxelotor for Patients With Sickle Cell Disease Who Have No Alternative Treatment Options

Status: open

An Open-Label, Expanded Access Protocol for Patients with Sickle Cell Disease Who Have No Alternative Treatment Options

Sickle Cell Disease

Contact Us Or call (251) 471-7714

Description

The purpose of this program is to provide early access to voxelotor for patients with sickle cell disease (SCD) who have exhausted alternative treatment options and are ineligible for actively-recruiting clinical trials of voxelotor.

This link will open in a new tab or window.